Please find below a list of literature which you can download or order.
A 71-Year-Old Woman with Multiple Myeloma Status after Stem Cell Transplantation
[ REF:MKG648]
Author: Leslie J. Donato, Steven R. Zeldenrust, David L. Murray, and Jerry A Katzmann
Journal Reference: Clinical Chemistry 57: 12 1645-1649 (2011)
Novel M-Component Based Biomarkers in Waldenstrom's Macroglobulinemia
[ REF:MKG646]
Author: Xavier Leleu
Journal Reference: Clinical Lymphoma, Myeloma & Leukemia, Vol. 11, No. 1 164-167, 2011
Pediatric Reference Intervals for Immunoglobulin G and its Subclasses with Siemens Immunonephelometric Assays
[ REF:MKG618]
Author: Antony Parker
Journal Reference: CLB-07570 Available online only.
Renal Failure in Multiple Myeloma: A Medical Emergency
[ REF:MKG615]
Author: B Wirk
Journal Reference: Bone Marrow Transplantation (2011), 1-3
Changes in Serum-Free Light Chain Rather Than Intact Monocolonal Immunoglobulin Levels Predicts Outcome Following Therapy in Primary Amyloidosis
[ REF:MKG614]
Author: Shaji K. Kumar, Angela Dispenzieri, Martha Q. Lacy
Journal Reference: Published online on 2nd December 2010 in Wiley Online Library DOI: 10.1002/ajh.21948
Use of Serum Free Light Chain Analysis and Urine Protein Electrophoresis for Detection of Monoclonal Gammopathies
[ REF:MKG612]
Author: Stephen Holding
Journal Reference: Clin Chem Lab Med 2011;49(1) DOI 10.1515/CCLM.2011.010
Prevalence and Risk of Progression of Light-Chain Monoclonal Gammopathy of Undetermined Significance: a Retrospective Population-Based Cohort Study
[ REF:MKG608]
Author: Angela Dispenzieri
Journal Reference: Lancet 2010; 375: 1721-28
Management options for cast nephrology in multiple myeloma
[ REF:MKG604]
Authors: Paul Cockwell and Calin Hutchison
Journal Reference: Current Opinion in Nephrology and Hypertension 2010, 19:550-555
Screening Panels for Monoclonal Gammopathies: Time to Change
[ REF:MKG583]
Author: Jerry A Katzmann
Journal Reference: Clinical Biochemical Review, 2009; 30:105-111
Advances in understanding monoclonal gammopathy of undetermined significance as a precursor of multiple myeloma
[ REF:MKG569]
Author: Weiss BM & Kuehl WM
Journal Reference: Expert Rev Hematol 2010; 3:165-174
Serum free light chains in chronic lymphocytic leukemia: light at the end of the tunnel?
[ REF:MKG568]
Author: Levoguer A, et al.
Journal Reference: CLI June 2010
New Tools for Detecting Occult Monoclonal Gammopathy, A Cause of Secondary Osteoporosis
[ REF:MKG565]
Author: Faiman B & Licata AA
Journal Reference: Cleveland Clinic Journal of Medicine, April 2010; 77:273-278
Serum Immunoglobulin Free Light Chains in Severe Forms of Atopic Dermatitis
[ REF:MKG564]
Author: Kayserova J, et al
Journal Reference: Scandinavian Journal of Immunology 2010;71:312-316
Monoclonal gammopathy of undetermined significance (MGUS) and smoldering (asymptomatic) multiple myeloma: IMWG consensus perspectives risk factors for progression and guidelines for monitoring and management
[ REF:MKG563]
Author: Kyle RA, Durie BMG, Rajkumar SV et al.
Journal Reference: Leukemia (2010); 24:1121-1127
Serum-free light chain assessment in hepatitis C virus-related lymphoproliferative disorders
[ REF:MKG555]
Author: Terrier B, S
Journal Reference: Ann Rheum Dis January 2009; 68:89-93
Serum immunoglobulin free light chain assesment in rheumatoid arthritis and primary Sjogren's syndrome
[ REF:MKG554]
Author: Gottenberg JE, Aucouturier F, Goetz J, et al
Journal Reference: Ann Rheum Dis January 2007; 66:23-27
Circulating Serum Free Light Chains As Predictive Markers of AIDS-Related Lymphoma
[ REF:MKG553]
Author: Landgren O, Goedert JJ, Rabkin CS, et al
Journal Reference: J Clin Oncol 2010; 28
Serum free light chain assessment in monoclonal gammopathy and kidney disease
[ REF:MKG549]
Author: Hutchison CA, Kolitha Basnayake and Paul Cockwell
Journal Reference: Nature Reviews November 2009; 5:621-627
Serum free light chain assay reduces the need for serum and urine immunofixation electrophoresis in the evaluation of monoclonal gammopathy
[ REF:MKG543]
Author: Richard B Fulton and Suran L Fernando
Journal Reference: Annals of Clinical Biochemistry 2009; 46:407-412
Heavy/Light-Chain Analysis of Monoclonal Gammopathies
[ REF:MKG537]
Author: David F. Keren.
Journal Reference: Clin Chem 2009;55:9:1606-1608
Assessment of Monoclonal Gammopathies by Nephelometric Measurement of Individual Immunoglobulin k/l Ratios
[ REF:MKG536]
Authors: AR Bradwell, et al.
Journal Reference: Clinical Chemistry - 55:9 1646-1655 (2009)
Screening panels for detection of monoclonal gammopathies
[ REF:MKG535]
Author: Jerry A Katzmann, Robert A Kyle, Joanne Benson et al.
Journal Reference: Clinical Chemistry August 2009; 55(8):1517-1522
Inaccuracies in 24-hour testing for monoclonal gammopathies
[ REF:MKG525]
Author: DS Siegel, L McBride, E Bilotti et al
Journal Reference: LabMedicine June 2009;40(6):341-344 doi: 10.1309/LMXYGLRB6YEBWHCJ
Are renal reference intervals required when screening for plasma cell disorders with serum free light chains and serum protein electrophoresis?
[ REF:MKG524]
Author: Abadie, J.M., K.H. van Hoeven, and J.M. Wells
Journal Reference: Am J Clin Pathol, 2009. 131(2): p. 166-71.
Utility of serum free light chain analysis when screening for lymphoproliferative disorders
[ REF:MKG523]
Author: EJD Robson, J Taylor, C Beardsmore et al
Journal Reference: LabMedicine June 2009;4(6):325-329 doi:10.1309/M6YUPSL3EIR7KE
Staging systems and prognostic factors as a guide to therapeutic decisions in multiple myeloma
[ REF:MKG521]
Author: M Kyrtsonis, D Maltezas, T Tzenou, E Koulieris, A Bradwell
Journal Reference: Seminars in Hematology, April 2009;46(2):110-117 doi: 10.1053/j.seminhematol.2009.02.004
Treatment of acute renal failure secondary to multiple myeloma with chemotherapy and extended high cut-off hemodialysis.
[ REF:MKG516]
Author: Hutchison CA, et al
Journal Reference: Clin J Am Soc Nephrol 2009;4:745-54
International Myeloma Working Group Guidelines for serum-free light chain analysis in multiple myeloma and related disorders
[ REF:MKG514]
Authors: Dispenzieri, et al.
Journal Reference: Lukemia (2009) 23, 215-224
Serum free light chain measurement aids the diagnosis of myeloma in patients with severe renal failure
[ REF:MKG493]
Author: Colin A Hutchison, Tim Plant, Mark Drayson, Paul Cockwell, Melpomeni Kountouri, Kolitha Basanayake, Stephen Harding, Arthur R Bradwell and Graham Mead.
Journal Reference: BMC Nephrology 2008;9:11 doi: 10.1186/1471-2369-9-11
Quantitative assessment of serum and urinary polyclonal free light chains in patients with chronic kidney disease
[ REF:MKG491]
Author: C. Hutchison, S. Harding, P Hewins et al
Journal Reference: Clin J Am Nephrology 3: 1684-1690, 2008
'Light chain escape-multiple myeloma'- an escape phenomenon from plateau phase: report of the largest patient series using LC-monitoring
[ REF:MKG487]
Author: Kuhnemund, A. et al.
Journal Reference: J Cancer Res Clin Oncol, 2008. doi 10.1007/s00432-008-0470-7
Quantitation of serum free light chains in combination with protein electrophoresis and clinical information for diagnosing multiple myeloma in a general hospital population
[ REF:MKG486]
Author: Piehler, A. P., et al.
Journal Reference: Clin Chem, 2008. 54(11): p. 1823-30.
Prognostic value of the serum free light chain ratio in newly diagnosed myeloma: proposed incorporation into the international staging system
[ REF:MKG452]
Author: CLH Snozek, JA Katzmann, RA Kyle, A Dispenzieri, DR Larson, TM Therneau, LJ Melton III, S Kumar, PR Greipp, RJ Clark and SV Rajkumar
Journal Reference: Leukemia advance online publication, 3 July 2008; doi:10.1038/leu.2008.171
Immunoglobulin free light chain ratio is an independent risk factor for progression of smoldering (asymptomatic) multiple myeloma
[ REF:MKG414]
Author: Angela Dispenzieri, Robert A. Kyle, Jerry A. Katzmann, Terry M. Therneau, Dirk Larson, Joanne Benson, Raynell J. Clark, L. Joseph Melton III, Morie A. Gertz, Shaji K. Kumar, Rafael Fonseca, Diane F. Jelinek, S. Vincent Rajkumar
Journal Reference: Blood 2008 111(2):785-789
Value of Serum Free Light Chain Testing for the Diagnosis and Monitoring of Monoclonal Gammopathies in Hematology.
[ REF:MKG405]
Author: Sundar Jagannath
Journal Reference: Clinical Lymphoma and Myeloma 2007 7(8):518-523
The Kidney in Plasma Cell Dyscrasias
[ REF:MKG383]
Author: Editor: G.A. Herrera
Journal Reference: Contributions to Nephrology, volume 153. Published by Karger.
High serum-free light chain levels and their rapid reduction in response to therapy define an aggressive multiple myeloma subtype with poor prognosis
[ REF:MKG381]
Author: Frits van Rhee, Vanessa Bolejack, Klaus Hollmig, Mauricio Pineda-Roman, Elias Anaissie, Joshua Epstein, John D. Shaughnessy Jr, Maurizio Zangari, Guido Tricot, Abid Mohiuddin, Yazan Alsayed, Gail Woods, John Crowley, and Bart Barlogie
Journal Reference: Blood, 2007; 110(3):827-832
Serum-Free Light Chain - A New Biomarker for Patients with B-Cell Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia
[ REF:MKG379]
Author: William Martin, Roshini Abraham, Tait Shanafelt, Raynell J. Clark, Nancy Bone, Susan M. Geyer, Jerry A. Katzmann, Arthur Bradwell, Neil E. Kay, and Thomas E. Witzig
Journal Reference: Translational Research, The Journal of Laboratory and Clinical Medicine, 2007; 149(4):231-236
Prognostic value of serum free light chain ratio at diagnosis in multiple myeloma
[ REF:MKG370]
Author: Marie-Christine Kyrtsonis, Theodoros P. Vassilakopoulos, Nicoletta Kafasi, Sotirios Sachanas, Tatiana Tzenou, Argiroula Papadogiannis, Zacharoula Galanism Christina Kalpadakis, Maria Dimou, Elias Kyriakou, Maria K. Angelopoulou, Maria N. Dimopoulou, Marina P. Siakantaris, Evangelia M. Dimitriadou, Styliani I. Kokoris, Panayiotis Panayiotidis and Gerassimos A. Pangalis
Journal Reference: British Journal of Haematology 2007; 137:240-243
Monitoring serum free light chains in patients with multiple myeloma who achieved negative immunofixation after allogeneic stem cell transplantation
[ REF:MKG347]
Author: Ulrike M
Journal Reference: haematologica 2007; 92:275-276
Efficient Removal of Immunoglobulin Free Light Chains by Hemodialysis for Multiple Myeloma: In Vitro and In Vivo Studies
[ REF:MKG344]
Author: Colin A. Hutchison, Paul Cockwell, Steven Reid, Katie Chandler, Graham P. Mead, John Harrison, John Hattersley, Neil D. Evans, Mike J. Chappell, Mark Cook, Hermann Goehl, Markus Storr, and Arthur R. Bradwell
Journal Reference: J Am Soc Nephrol 2007 18: 886-895
Elimination of the Need for Urine Studies in the Screening Algorithm for Monoclonal Gammopathies by Using Serum Immunofixation and Free Light Chain Assays
[ REF:MKG343]
Author: Jerry A. Katzmann, Angela Dispenzieri, Robert A. Kyle, Melissa R. Snyder, Matthew F. Plevak, Dirk R. Larson, Roshini S. Abraham, John A. Lust, L. Joseph Melton III, and S. Vincent Rajkumar.
Journal Reference: Mayo Clin Proc. 2006;81(12):1575-1578
Serum Free Light Chains: An Alternative to the Urine Bence Jones Proteins Screening Test for Monoclonal Gammopathies
[ REF:MKG326]
Authors: PG Hill, JM Forsyth, B Rai & S Mayne
Journal Reference: Clinical Chemistry 52:9 1743-1748 (2006)
International uniform response criteria for multiple myeloma
[ REF:MKG320]
Author: BGM Durie et al.
Journal Reference: Leukemia (2006) 20, 1467-1473
Absolute values of Free Light chains are prognostic in patients with primary amyloidosis undergoing peripheral blood stem cell transplant
[ REF:MKG311]
Author: Dispenzieri et al.
Journal Reference: Blood 2006; 107: 3378-3383
Serum free light chain FLC measurement can aid capillary zone electrophoresis in detecting subtle FLC-producing M proteins
[ REF:MKG261]
Author: Nasir A, Bakshi, Ronald Gulbranson, Dabiel Gartska, Arthur R. Bradwell, and David F. Keren.
Journal Reference: Am J Clin Pathol 2005;124:214-218
Serum free light chains for monitoring multiple myeloma
[ REF:MKG228]
Author: G. P. Mead, H. D. Carr-Smith, M. T. Drayson, G. J. Morgan, J. A. Child and A. R. Bradwell.
Journal Reference: BJH 2004;126:348-354
Guidelines on the diagnosis and management of AL amyloidosis
[ REF:MKG227]
Author: United Kingdom Myeloma Forum on behalf of the British Committee for Standards in Haematology (BCSH).
Journal Reference: BJH 2004;125:681-700
Free Immunoglobulin Light-Chain Serum Levels in the Follow-up of Patients With Monoclonal Gammopathies: Correlation With 24-hr Urinary Light-Chain Excretion
[ REF:MKG222]
Author: Marie-Alexandra Alyanakian, Aicha Abbas, Richard Delarue, Bertrand Arnulf and Pierre Aucouturier.
Journal Reference: Am J Hematology 2004;75:246-248
Outcome in systemic AL amyloidosis in relation to changes in concentration of circulating free immunoglobulin light chains following chemotherapy
[ REF:MKG200]
Author: Helen J. Lachmann, Ruth Gallimore, Julian D. Gillmore, Hugh D. Carr-Smith, Arthur R. Bradwell, Mark B. Pepys and Philip N. Hawkins.
Journal Reference: BJH 2003;122:78-84
Serum test for assessment of patients with Bence Jones myeloma
[ REF:MKG189]
Author: Arthur R Bradwell, Hugh D Carr-Smith, Graham P Mead, Timothy C Harvey, Mark T Drayson.
Journal Reference: Lancet 2003;361:489-491
Serum free light-chain measurements for identifying and monitoring patients with nonsecretory multiple myeloma
[ REF:MKG183]
Author: Mark Drayson, Liang X. Tang, Roger Drew, Graham P. Mead, Hugh Carr-Smith, and Arthur R. Bradwell.
Journal Reference: Blood 2001;97:9:2900-2902
